期刊文献+

急性缺血性脑卒中患者血清胱抑素C水平与脑白质病变的相关性 被引量:5

Correlation between serum cystatin C and white matter lesions in patients with cerebral ischemic stroke
原文传递
导出
摘要 目的探讨急性缺血性脑卒中患者血清胱抑素C水平与脑白质病变(WMLs)的相关性。方法符合诊断标准的缺血性脑卒中患者105例,根据Fazekas量表评估WMLs严重程度分为无或轻度WMLs组和重度WMLs组,比较两组相关资料的差异,分析重度WMLs的危险因素。结果两组年龄、高血压和胱抑素C水平存在统计学差异(P〈0.05)。年龄(OR=1.06,95%CI=1.01-1.12,P〈0.05)和胱抑素C水平(OR=1.32,95%CI=1.07-1.55,P〈0.01)是急性缺血性脑卒中患者伴发重度WMLs的独立危险因素。结论年龄和胱抑素C水平是急性缺血性脑卒中患者伴发重度WMLs的独立危险因素。 Objective To investigate the correlation between serum cystatin C and white matter lesions(WMLs)in the patients with cerebral ischemic stroke.Methods On the basis of Fazekas scores,105 patients with cerebral ischemic stroke were assigned into two groups of A(without or with mild WMLs,63 cases)and B(with severe WMLs,42 cases).Clinical data were compared between two groups and the risk factors related to WMLs were analyzed.Results The differences in age,hypertension and cystatin C between two groups were significant(P〈0.05).The age(OR=1.06,95%CI=1.01-1.12,P〈0.05)and cystatin C(OR=1.32,95%CI=1.07-1.55,P〈0.01)were the independent risk factors for severe WMLs.Conclusion The age and cystatin C level are the independent risk factors for severe WMLs in the patients with cerebral ischemic stroke.
出处 《江苏医药》 CAS 2016年第4期414-416,共3页 Jiangsu Medical Journal
关键词 胱抑素C 缺血性卒中 脑白质病变 Cystatin C Cerebral ischemic stroke White matter lesions
  • 相关文献

参考文献9

  • 1Henninger N,Lin E,Baker SP,et al.Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion[J].Cerebrovasc Dis,2012,33(6):525-531.
  • 2Debette S,Markus HS.The clinical importance of white matter hyperintensities on brain magnetic resonance imaging:systematic review and meta-analysis[J].BMJ,2010,341(7):C3666.
  • 3Angelidis C,Deftereos S,Giannopoulos G,et al.Cystatin C:an emerging biomarker in cardiovascular disease[J].Curr Top Med Chem,2013,13(2):164-179.
  • 4Pantoni L,Simoni M,Pracucci G,et al.Visual rating scales for age-related white matter chages(leukoaraiosis):can the heterogeneity be reduced[J]?Stroke,2002,33(12):2827-2833.
  • 5Lee M,Saver JL,huang WH,et al.Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk population:a meta-analysis[J].Cardiovasc Qual Outcomes,2010,3(6):675-683.
  • 6Wada M,Nagasawa H,Kawanami T,et al.Cystatin C as an index of cerebral small vessel disease:results of a crosssectional study in community-based Japanese elderly[J].Eur J Neurol,2010,17(3):383-390.
  • 7汪飞,廖庆红,赵守才,储照虎.急性脑梗死患者血清Cyst-C水平变化及其与TOAST分型关系的研究[J].卒中与神经疾病,2012,19(3):149-152. 被引量:9
  • 8Grueter BE,Schulz UG.Age-related cerebral white matter disease(leukoaraiosis):a review[J].Postgrad Med,2012,88(1036):79-87.
  • 9Wakita H,Tomimoto H,Akiguchi I,et al.Axonal damage and demyelination in the white matter chronic cerebral hyperfusion in the rat[J].Brain Res,2002,924(1):63.

二级参考文献14

  • 1Simonsen O,Grubb A, Thysell H. The blood serum concentration of Cystatin C (gamma-trace) as a measure of the glomerular fil- tration rate. Scand J Clin Lab Invest, 1985,45 (2) : 97-101.
  • 2Taqlieri N, Koeniq W, Kaski JC. Cystatin C and cardiovascular risk. Ann Biol Clin, 2010,68(5):517-529.
  • 3Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Stroke,1993,24(1 ):35-41.
  • 4Gao S, Wang YJ, Xu XD, et al. Chinese ischemic stroke sub- classification. Front Neurol,2011,2(15):2-6.
  • 5Marnane M, Duqqan OC, Merwick A, et al. Stroke subtype classi- fiction to mechanism specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. Stroke, 2010,41 (8) : 1579-1586.
  • 6Amaremco P, Bngousslavsky J, Caplan LR, et al. New approach to stroke subtyping the A-S-C O (phenotypic) classification of stroke. Cerebr-ovasl Dis, 2009,27 ( 11 ) : 5112-508.
  • 7Arpegard J,Ostergren J, de Faire U, et al. Cystatin C a market of peripheral atherosclerotic disease. Atheroselerosis, 2008, 199 (2) :397-401.
  • 8Koenig W, Twardella D, Brenner H, et al. Plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary ear- diovascular events: more than simply a marker of glomerular filtration nate. Clin Chem,2005,51 (2) :321-327.
  • 9Noto D,Cefalu AB,Barbagllo CM,et al. Cystatin C levels are de creased in acute myocardial infarction:effect of cystatin C G73A gene poly- morphism on plasma levels. Int J Cardiol,2005, 101 (2) :213-217.
  • 10Barka T, Van der, Noen H. Expression of the cyateine proteinase inhibitior Cystatin C gene in rat heart:use of digoxigenin labeled probes generated by polymerase chain reaction directly for in situ and morthen blot hybridizations. J Histochem Cytochem, 1993, 41 (12) : 1683-1687.

共引文献8

同被引文献36

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部